Eli Lilly Corp. buy SVB Leerink LLC
Start price
18.12.25
/
50%
€907.10
Target price
18.12.26
-
Performance (%)
17.58%
Price
10.08.26
€1,066.6
Summary
This prediction is currently active. The prediction currently has a performance of 17.58%. This prediction currently runs until 18.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 9.496% | 9.496% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€758.50
27.04.26
27.04.26
€902.26
27.04.27
27.04.27
40.62%
10.08.26
10.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€920.00
07.02.26
07.02.26
€1,097.5
07.02.27
07.02.27
15.93%
10.08.26
10.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€807.50
10.11.25
10.11.25
€955.18
10.11.26
10.11.26
32.09%
10.08.26
10.08.26